CompletedPhase 2NCT04300426

Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue)

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oslo University Hospital
Principal Investigator
Anna-Maria Hoffmann-Vold, MD, PhD
Oslo University Hospital
Intervention
"ACHIM" as solute (10^9 intestinal microbes/ml)(drug)
Enrollment
75 enrolled
Eligibility
18-85 years · All sexes
Timeline
2020 – 2022

Study locations (4)

Collaborators

South-Eastern Norway Regional Health Authority · Haukeland University Hospital · St. Olavs Hospital · University Hospital of North Norway

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04300426 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials